Women CEOs at large US public companies once again outearned their male counterparts in 2025. They earned 11% more than male CEOs in the S&P 500 and about 3% more in the Russell 3000. Despite outearning them, women's representation at the top remains minimal: They hold 7% of CEO positions in the S&P 500 and […]
ScaleOps expands its cloud resource management platform to self-hosted GenAI models and GPU-based applications, enabling enterprises to run AI at scale with optimal performance and zero waste. ScaleOps, the market leader in cloud resource management, today announced the launch of its AI Infra Product, expanding its proven capabilities to manage resources for self-hosted AI models
Ally Financial Inc. (NYSE: ALLY) Chief Executive Officer Michael Rhodes will present at theGoldman Sachs US Financial Services Conference on Wednesday, December 10, 2025 at approximately 11:20 a.m. ET. https://mma.prnewswire.com/media/1743708/Ally_Financial_Logo.jpg A live webcast will be available on the day of the conference at http://www.ally.com/about/investor/under the Events and Presentations section of the Investor Relations website.A replay
Ardagh Glass Packaging-North America(AGP-North America), an operating business of Ardagh Group, today announced the launch of its improved e-commerce website, now live at BuyOurBottles.com, powered by Shopify. https://mma.prnewswire.com/media/415919/Ardagh_Group_Logo.jpg Originally launched in 2012, AGP-North America's BOB™ site (BuyOurBottles) became the first online platform to offer craft brewers the ability to purchase craft beer bottles online in
Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Sarepta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
Pomerantz LLP is investigating claims on behalf of investors ofAlvotech (“Alvotech” or the “Company”) (NASDAQ: ALVO).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Alvotech and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about
Pomerantz LLP is investigating claims on behalf of investors of Enovix Corporation (“Enovix” or the “Company”) (NASDAQ: ENVX).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Enovix and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for
Pomerantz LLP is investigating claims on behalf of investors of Bicycle Therapeutics plc (“Bicycle” or the “Company”) (NASDAQ: BCYC).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Bicycle and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
Pomerantz LLP is investigating claims on behalf of investors of The Bancorp, Inc. (“Bancorp” or the “Company”) (NASDAQ: TBBK).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext. 7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Bancorp and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click
Pomerantz LLP is investigating claims on behalf of investors of Surgery Partners, Inc. (“Surgery Partners” or the “Company”) (NASDAQ: SGRY).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext. 7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Surgery Partners and certain of its officers and/or directors have engaged in securities fraud or other unlawful business